Stockscreener 앱 받기
0.4256
1.75%
-0.0076
시간 외 거래:
.44
0.0144
+3.38%
전일 마감가:
$0.4332
열려 있는:
$0.431
하루 거래량:
444.22K
Relative Volume:
0.22
시가총액:
$60.25M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.3153
EPS:
-1.35
순현금흐름:
$-55.17M
1주 성능:
-3.43%
1개월 성능:
+15.34%
6개월 성능:
-30.24%
1년 성능:
-93.40%
1일 변동 폭
$0.422
$0.454
1주일 범위
$0.422
$0.4833
52주 변동 폭
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
명칭
Applied Therapeutics Inc
전화
212-220-9226
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.4256 | 62.92M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-23 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | 개시 | William Blair | Outperform |
| 2024-03-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-22 | 개시 | Leerink Partners | Outperform |
| 2022-01-04 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-08-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-06-25 | 재개 | Goldman | Neutral |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-04-22 | 개시 | Goldman | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2019-06-10 | 개시 | Citigroup | Buy |
| 2019-06-10 | 개시 | Cowen | Outperform |
| 2019-06-10 | 개시 | Robert W. Baird | Outperform |
모두보기
Applied Therapeutics Inc 주식(APLT)의 최신 뉴스
Applied Therapeutics Inc.’s Beta Climbs After Market VolatilityBuy Alerts With Low Risk Confirmation Noted - metal.it
Applied Therapeutics (APLT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
What institutional investors are buying Applied Therapeutics Inc. stockUnlock powerful investment tools for free - Jammu Links News
What are the latest earnings results for Applied Therapeutics Inc.Free Stock Selection - Jammu Links News
What are analysts’ price targets for Applied Therapeutics Inc. in the next 12 monthsOutstanding growth strategies - Jammu Links News
What catalysts could drive Applied Therapeutics Inc. stock higher in 2025Achieve breakthrough financial results - Jammu Links News
How does Applied Therapeutics Inc. generate profit in a changing economyInvest confidently with professional market insights - Jammu Links News
What are Applied Therapeutics Inc. company’s key revenue driversHigh-octane investment opportunities await - Jammu Links News
How volatile is Applied Therapeutics Inc. stock compared to the marketGet high-impact stock recommendations now - Jammu Links News
Published on: 2025-08-03 15:52:53 - Jammu Links News
Applied Therapeutics Inc. Stock Analysis and ForecastBuild a diversified portfolio for risk management - Jammu Links News
What drives Applied Therapeutics Inc. stock priceMaximize your portfolio’s growth potential - Jammu Links News
What analysts say about Applied Therapeutics Inc. stockBuild a portfolio that delivers consistent profits - Jammu Links News
What makes Applied Therapeutics Inc. stock price move sharplyEarnings Report Entry Points For Fast Growth - Jammu Links News
Applied Therapeutics Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Brokerages Set Applied Therapeutics Inc. (NASDAQ:APLT) PT at $6.10 - MarketBeat
What is the dividend policy of Applied Therapeutics Inc. stockValue Investing Picks For Every Investor - Jammu Links News
Is Applied Therapeutics Inc. still worth holding after the dipBuy Alerts With Low Risk Confirmation Noted - metal.it
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit – APLT - ACCESS Newswire
Wall Street Zen Upgrades Applied Therapeutics (NASDAQ:APLT) to Sell - MarketBeat
Published on: 2025-07-29 13:58:52 - metal.it
Why Applied Therapeutics Inc. stock attracts strong analyst attentionLow Capital High Return Stock Plans Reviewed - metal.it
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
How does Applied Therapeutics Inc. compare to its industry peersRemarkable growth - jammulinksnews.com
Applied Therapeutics (NASDAQ:APLT) Stock Price Down 5%What's Next? - MarketBeat
What is Applied Therapeutics Inc. company’s growth strategyMaximize your portfolio’s growth potential - jammulinksnews.com
Published on: 2025-07-28 02:44:29 - Jammu Links News
Is Applied Therapeutics Inc. a good long term investmentFree Consultation - PrintWeekIndia
Should I buy Applied Therapeutics Inc. stock before earningsFree Investment Risk Control - Jammu Links News
How Applied Therapeutics Inc. stock reacts to Fed policy changesTop Analyst Picks - Newser
Applied Therapeutics Inc (APLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):